A detailed history of Groupe La Francaise transactions in Boston Scientific Corp stock. As of the latest transaction made, Groupe La Francaise holds 632,131 shares of BSX stock, worth $61.5 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
632,131
Previous 335,082 88.65%
Holding current value
$61.5 Million
Previous $33.6 Billion 102.06%
% of portfolio
1.1%
Previous 0.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$89.7 - $107.41 $26.6 Million - $31.9 Million
297,049 Added 88.65%
632,131 $67.9 Billion
Q1 2025

May 14, 2025

BUY
$89.38 - $106.18 $3.46 Million - $4.11 Million
38,701 Added 13.06%
335,082 $33.6 Billion
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $24.8 Million - $27.1 Million
296,381 New
296,381 $25.9 Billion

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $139B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Groupe La Francaise Portfolio

Follow Groupe La Francaise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupe La Francaise, based on Form 13F filings with the SEC.

News

Stay updated on Groupe La Francaise with notifications on news.